Small Cap Stock Hester Biosciences Picks Record Date For Dividend

Small cap stock operating in agriculture & livestock sector Hester Biosciences Ltd fixed September 13, 2023 as the record date for dividend. Earlier, Hester Biosciences announced a dividend of Rs 8 per equity share for the FY 2023.

Hester Biosciences Sets Record Date For Dividend: According to the BSE filing of the company, "Cut-off date to determine list of members entitled to receive final dividend is Wednesday, 13 September 2023. The company fixed dividend payment date On or after Monday, 25 September 2023.

Earlier, the company declared a dividend at the rate of Rs 8 (Indian Rupees Eight only) per equity share of Rs 10 (Ten rupees) each fully paid-up of the Company for the financial year ended March 31, 2023.

Hester Biosciences Stock Performance & Return: Current market price of Hester Biosciences stock is Rs 1702.90 apiece with intraday gain of 0.40%. Its 52-week high price is Rs 2280.40 apiece and 52-week low price is Rs 1415.95 apiece, respectively. The small cap company has a market capitalisation of Rs 1448.63 crore. Hester Biosciences shares declined 5% in last 6-months, tumbled 19% in last 1-year, fell 24% in last 2-years, and gave 14% return in last 3-years.

Hester Biosciences Financial Outlook: The company for the quarter June 30, 2023 announced a jump of 26% in its consolidated total income at Rs 89.00 crore as against its last quarter total income of Rs 70.49 crore. It declared its latest quarter net profit after tax at Rs 5.34 crore.

Hester Biosciences About: Hester Biosciences Limited is one of India's leading animal healthcare companies and is the second largest poultry vaccine manufacturer in the country. Hester began was incorporated in 1987.

Disclaimer: The stock just highlights the dividend and is not a recommendation to buy, sell or hold. We have not done fundamental or technical analysis and have no opinion on the stock mentioned. Neither, the author nor Greynium Information Technologies should be held liable for ay losses. Please consult a professional advisor.